FDA recall D-1080-2019

Akorn, Inc. · Class III · drug

Product

Nystatin Oral Suspension, USP, 100,000 units per mL, 473 mL per bottle, Rx only, HI-TECH Pharmacal Co., Inc., Amityville, NY 11701, NDC 50383-587-16

Reason for recall

Failed Impurities/Degradation Specifications: Out of Specification for an unknown impurity was observed during the 18 month stability testing.

Distribution

AR and MS

Key facts

Status
Terminated
Initiation date
2019-03-28
Report date
2019-04-10
Termination date
2020-04-22
Voluntary/Mandated
Voluntary: Firm initiated
Location
Lake Forest, IL, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1080-2019